Introduction
Sepsis is a global health challenge of growingincidence,1,2 associated with high morbidity and mortality3.4.
Considerable advances have been made in the understanding of pathophysiology and management of sepsis in the past two decades. Clinicians should appreciate that sepsis is not a specific illness but a syndrome that may present in a variety of clinical settings. The affected individuals can be diverse in age, comorbidity, concurrent injuries including surgery, medications and the source and type of infection 5 ,6 . There is no gold standard for the diagnosis of sepsis. A new definition with criteria for early detection of sepsis named "sepsis 3" was released by the Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM)in February 2016. Although this is the most updated attempt at early recognition of sepsis,we must be mindful that periodic updating based on new insights is imperative.
Pathophysiology
The pathophysiology of sepsis is a complex interaction of microbial organism and host immune response involving inflammatory and coagulation pathways.
Role of the immune system
The immune system is activated by microbial cell wall products, resulting in a complex series of cellular and humoral responses. This results in the release of reactive oxygen free radicles, nitric oxide (NO), pro-teases, and pore-forming molecules that are bactericidal? while unwanted effects occur due to sepsis induced mitochondrial dysfunction 8 , such as vasodilatation and increased capillary permeability.
Inflammation, organ dysfunction and shock
Relative and absolute hypovolaemia due to vasodilatation and increased capillary permeability are compounded by reduced left ventricular contractility that result in hypotension followed by tissue hypoperfusion and shock. Cellular energy levels fall as metabolic activity begins to exceed production. However, cell death appears to be uncommon in sepsis, implying that cells shut down as part of the systemic response. This explains why sparse histological changes are found at autopsy and the rapid resolution of severe organ dysfunction such as anuria and hypotension, once the systemic inflammation resolves
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Evolution of the definitions of sepsis
Sepsis exists on a continuum of severity ranging from infection and bacteraemia to sepsis and septic shock, which can lead to multiple organ dysfunction syndrome (MODS) and death. The definitions of sepsis and septic shock have evolved since the early 1990s. The common problem encountered by all consensus definitions is maintaining sensitivity without affecting specificity3. Some critics claim that high sensitivity is preferred over specificity considering the severity of the problem 11 . Narrowing the criteria will reduce sensitivity, which leads to a greater risk for delayed diagnosis, which is a major concern especially for low and middle income countries.
Sepsis 1
In 1991 the first consensus conferenceon sepsis defined it as "a systemic inflammatory response (SIRS) to a new infection." This cornerstone definition mandated the presence of presumed or confiirmed infection and Sepsis presence of two of four SIRS criteria. Sepsis complicated by organ dysfunction was termed severe sepsis, which could progress to septic shock, defined as "sepsisinduced hypotension persisting despite adequate fluid resuscitation" 12 .
The SIRS criteria are no longer included in the new definitions as it is not always caused by an infection. Kaukonen et al reported based on a large review that SIRS criteria missed one in eight septic patients in the ICU 13 .
Sepsis 2
In 2001, the International Sepsis Definitions Task Force, expanded the list of diagnostic criteria for sepsis, severe sepsis and septic shock but did not offer alternative definitions due to lack of supporting evidence. For example, the diagnosis of sepsis was based on the presence of documented or suspected infection along with the presence of the following variables: general, inflammatory, hemodynamic, tissue perfusion and organ dysfunction 14 .
The major limitation of both these definitions and diagnostic criteria was an excessive focus on inflammation and a misleading model which assumed that sepsis follows a continuum through severe sepsis to shock. The definitions of sepsis, septic shock, and organ dysfunction have remained largely unchanged for more than 2 decades.
Sepsis 3
In 2016 the SCCM / ESICM convened a task force for the Third International Consensus Definitions on Sepsis 15 .
• "Sepsis is now defined as a life-threatening organ dysfunction caused by a dysregulated host response to infection."
Clinically, organ dysfunction is identified as an acute change in total Sequential Organ Failure Score (SOFA) ≥2 points consequent to an infection. The baseline SOFA score can be assumed to be zero in patients not known to have preexisting organ dysfunction.
A SOFA score ≥2 reflects an overall mortality risk of approximately 10% in a general hospital population with suspected infection emphasizing the seriousness of this condition and the need for prompt intervention.
qSOFA (quick SOFA) -A simpler bedside tool to be used outside of ICU (since SOFA score is an ICU based mortality score). This score is expected to promptly identify patients with suspected infection who are likely to have a prolonged ICU stay or to die in the hospital.
• Septic shock is a subset of sepsis in which underlying circulatory and cellular/metabolic abnormalities are profound enough to substantially increase mortality.
Septic shock is identified with persisting hypotension requiring vasopressors to maintain the mean arterial pressure (MAP) ≥65 mm Hg and with a serum lactate level >2 mmol/L despite adequate volume resuscitation. These criteria are linked to a hospital mortality in excess of 40% 15 .
It is noteworthy that there is no longer a condition called severe sepsis.
qSOFAScore
-Alteration in mental status -Systolic blood pressure ≤100 mm Hg -Respiratory rate ≤22/min.
A score ≤2 will identify patients who are likely to have poor outcomes.
What are the limitations of Sepsis 3?
SOFA and qSOFA scores are only predictors of mortality; neither diagnostic nor prognostic.
Reliance is on clinical suspicion in relation to the score. Moreover, SOFA is a complicated ICU scoring system that is not used globally. (e.g. many Australian ICUs use APACHE score instead).
qSOFA has neither been prospectively validated nor fully established. At the University of Chicago, USA a retrospective study carried out failed to validate the qSOFA score 15 . It was shown that qSOFA score has poor sensitivity and is a late indicator of clinical deterioration. The same study found that National Early Warning Score (NEWS-recommended by NICE guidelines, UK Sepsis Trust, Royal College of Emergency Medicine) which uses data that is equally accessible at the bed side as a having better sensitivity and specificity 17, 18 .
It is important to remember that despite these limitations,the initial definitions and guidelines resulted in global reduction in sepsis related morbidity and mortality 11 .
Management
Sepsis and septic shock being medical emergencies, warrant immediate resuscitation and treatment.
In 2001, Rivers et al published a single center RCT that described early goal directed therapy (EGDT) to improve the outcomes of sepsis 19 . Based on this trial, in 2004 the Surviving Sepsis Campaign (SSC) introduced the "bundle approach" to manage sepsis. What the SSC recommended was to have a protocolized quantitative resuscitation 20 . This guideline attracted widespread attention and improved global sepsis survival. Limitations of the Rivers study were subsequently highlighted.
The SSC guidelines were revised in 2008 and in 2012. Guidelines issued in 2012 described initial resuscitation in a "Three hour bundle" to be followed by a "Six hour bundle" 21 . 
Sepsis Definition
• Life threatening organ dysfunction caused by dysregulated host response to infection
• No severe sepsis category
• At least 30 ml/kg in first 3 hours • Crystalloid fluid (no recommendations on 0.9% NaCIvs balanced solution)
• Albumin if patients require "substantial" fluids (weak)
• Protocolized care including:
CVP ScVO2
• Normalize lactate • Combination therapy (double coverage) for neutropenic patients and pseudomonas
• Unable to make recommendation on non-invasive ventilation The SSC guidelines do not cover every aspect of managing critically ill patients and their application should be supplemented by generic best practice and specific treatment as required.
Even though protocolized resuscitation recommended by the SSC has not shown to be superior to standard care in the ARISE 23 , ProCESS 24 and ProMISE 25 trials, one must bear in mind that all these trials were carried out in resource-rich settings. The majority of the participating hospitals were tertiary care or teaching facilities.
Available data on sepsis management of adults in resource-limited settings suggest that a high mortality is associated with ineffective management including delayed and improper empiric antimicrobial therapy as well as sub-optimal fluid resuscitation 1, 26 .
Hence the authors of this article feel that a protocolized approach to sepsis management still plays a major role in improving outcomes in resource-limited settings.
Therapeutic priorities in the management
Initial resuscitation
• All patients should receive supplemental oxygen.
Stabilizing the airway and maintaining breathing must be addressed. If intubation is warranted it is important to use cardio stable drugs in doses that cause minimum haemodynamic changes.
• Early effective fluid resuscitation is crucial in sepsisinduced tissue hypoperfusion or septic shock. Hypotension is the most common sign of critical tissue hypoperfusion. Tissue hypoperfusion can also occur in the absence of hypotension, especially during early sepsis. Hence it is important to look for other signs of tissue hypoperfusion (e.g. confusion, reduced urine output).
• Resuscitation must aim to normalize lactate levels (since lactate is a marker of tissue hypoperfusion).
• As highlighted in SSC 3 hour bundle, up to 30mL/kg of intravenous crystalloid fluid can be given within the first 3 hours. Crystalloids are recommended as the fluid of choice. (e.g. balanced crystalloids or saline). Current guidelines do not state a difference in outcome between normal saline and balanced salt solutions. It is reasonable to use either type of fluid whilst being mindful of the side effects. (e.g. hypercholareamic metabolic acidosis when largevolumes of normal saline is used).
• Aditionally albumin (4-5%) is recommended when patients require substantial amounts of fluids 27 . Use of hydroxyethyl starches is not recommended.
• Following initial resuscitation, additional fluids should be guided by frequent reassessment of hemodynamic status (see 6 hour bundle). This should include a thorough clinical examination for physical signs (capillary refill, heart rate, blood pressure, arterial oxygen saturation, respiratory rate, temperature, urine output and conscious level) as well as available non invasive or invasive monitoring.
• If the clinical examination yields no clear diagnosis, dynamic assessment of fluid responsiveness with passive leg raise or fluid challenge, bedside cardiovascular ultrasound, CVP and ScvO2 measurements are indicated.
• Fluid challenges are continued as long as hemodynamic parameters continue to improve.
• Once the patient becomes haemodynamically stable with no signs of tissue hypoperfusion, individualized and conservative fluid management should be ensured to prevent overloading.
Vasopressors
For patients in septic shock requiring vasopressors (hypotension or signs of tissue hypoperfusion after initial fluid resuscitation) the initial target MAP is 65 mmHg. Noradrenaline should be the vasopressor of choice. Adrenaline should be added if target MAP is not achieved. Vasopressin (up to 0.03 U/min) can be added to reduce the dose of noradrenaline. Dopamine is not used as an alternative to noradrenaline except in highly selected patients such as those with inappropriately low heart rates (absolute or relative bradycardia) or at low risk for tachyarrhythmias.
Ionotropes
A trial of dobutamine infusion up to 20 micrograms/ kg/min may be administered or added to vasopressor in the presence of (a) myocardial dysfunction indicated by elevated cardiac filling pressures and low cardiac output, or (b) ongoing hypoperfusion (e.g. low CV oxygen saturation or high lactate) despite achieving adequate intravascular volume and MAP.
Antimicrobial therapy
Administration of intravenous antimicrobials must be initiated as soon as possible and definitely within one hour of the diagnosis. Blood and appropriate cultures must be obtained before starting antibiotics. Nevertheless, this must not delay the commencement of antimicrobials by more than one hour.
Empiric broad-spectrum therapy with one or more antimicrobials is recommended and de-escalated once sensitivities are established and/or adequate clinical improvement is noted. Please refer the guidelines issued by the Sri Lanka College of Microbiologists 28 .
The human cost of delaying effective antibiotic treatment is well established. The landmark study by Kumar et al in 2006 of 2,731 ICU based patients with septic shock in USA and Canada, showed a significant correlation between a delay in effective antibiotic therapy and in-hospital mortality 29 . This has been later corroborated by many other clinical trials 30 .
The inappropriate practice awaiting the next fixed drug delivery time to commence or to change antibiotics must be discouraged.
Source control
Once the diagnosis is made this must be implemented early when medically and logistically practical. Daily assessment and removal of unnecessary intravascular devices as possible sources of infection is vital and determines the degree of improved outcomes.
Corticosteroids
Intravenous hydrocortisone at a dose of 200 mg per day is recommended only if adequate fluid resuscitation and vasopressor therapy are not able to restore hemodynamic stability.
Glucose control
It is recommended to maintain blood glucose levels <180 mg/dL with insulin infusions.
Mechanical ventilation
In adult patients with sepsis-induced acute respiratory distress syndrome (ARDS), lung protective ventilatory strategies should be implemented.
Conservative fluid management should be used for patients with established sepsis-induced ARDS who do not have evidence of tissue hypoperfusion.
Renal replacement therapy
Continuous or intermittent renal replacement therapy (RRT) is indicated in patients with sepsis and acute kidney injury.
Venous thromboembolism prophylaxis
Pharmacologic and mechanical prophylaxis is recommended against venous thromboembolism (VTE) in the absence of contraindications.
Stress ulcer prophylaxis
This should be initiated inpatients with sepsis or septic shock who have risk factors for gastrointestinal bleeding.
Nutrition
As with any critically ill patient, administration of early parenteral nutrition is not recommended. Initiation of early hypocaloric enteral feeds to be advanced according to patient tolerance can be recommended.
Setting goals of care
Goals of care and prognosis should be discussed with patients and families. This should be incorporated into the treatment and end-of-life care planning.
Conclusions
• The reported incidence of sepsis is increasing.
Morbidity and mortality rates are significant, as are costs to health systems around the globe.
• New definitions and management guidelines have been released with the aim of early diagnosis and escalation of management which is the key to improved outcomes.
• These definitions and guidelines will keep evolving as sepsis becomes better understood.
• Clinicians should be vigilant to ensure adherence to best practices when treating patients with sepsis. Several trials have shown that outcomes from standard care are comparable to those from protocolized quantitative resuscitation recommended by the SSC. However, it should be noted that these trials were de Lanerolle M I, Samaranayake W R, Ranatunga K performed in resource-rich settings. The protocolized approach may remain to be more suitable in resourcelimited settings as delays may occur with standard care in the initiation and management of sepsis.
